Clinuvel Pharmaceuticals LimitedASX: CUV

Clinuvel to start a Phase II vitiligo study in Singapore

Feb 10, 2016 at 8:19 PM EST · Issued by Clinuvel Pharmaceuticals Limited

Filed with ASX · Feb 10, 2016 at 8:19 PM EST

On 6ix: 6ix.com/news/clinuvel-to-start-a-phase-ii-vitiligo-study-in-singapore

Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27 Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call

View Attachment

6ix hasn’t read this filing yet.

Clinuvel Pharmaceuticals Limited on 6ix

Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.

Follow Clinuvel Pharmaceuticals